Marion D W, Pollack I F, Lund R D
Department of Neurosurgery, University of Pittsburgh School of Medicine, PA 15261.
Brain Res. 1990 Jun 11;519(1-2):133-43. doi: 10.1016/0006-8993(90)90071-i.
We studied the histological and immunological characteristics of graft rejection in the rodent central nervous system (CNS) using embryonic mouse neocortex transplanted into the CNS of neonatal rats. Grafts from animals aged 8-145 days (n = 210) were examined using standard histological techniques for demonstrating cell morphology and fiber projections. Immunohistochemical techniques were used to identify graft projections into the host CNS. The incidence of graft rejection was 18% for animals between 18 and 30 days of age, but increased abruptly to 73% for animals older than 30 days. No graft rejection was seen in animals younger than 18 days. In a smaller group of xenograft recipient rats sacrificed at specific time points before and after one month of age, detailed immunohistochemical studies were performed to correlate the histological appearance of the graft with the level of major histocompatibility complex (MHC) class I and II immunoreactivity, and microglial, astrocytic and lymphocytic staining within the graft and host brain. Evidence of mild rejection as manifested by the appearance of scattered lymphocytes within the graft coincided with the development of Class I and II immunoreactivity within the graft and at the graft-host interface, which was demonstrated in some animals as early as 24 days. At 29 days of age, rejecting grafts showed diffuse MHC expression within the graft and at the graft-host interface; in contrast, unrejected grafts failed to show MHC immunoreactivity. Thirty-four day-old grafts often showed severe rejection with perivascular lymphocytic cuffing within the graft and in host parenchyma remote from the graft associated with increased MHC immunoreactivity within the host brain. In grafts older than 34 days there was frequently a violent rejection reaction with disruption of the cytoarchitecture of the graft and surrounding host tissues, and widespread MHC antigen expression. Immunosuppression with cyclosporin A was effective in avoiding rejection. The high incidence of rejection with neocortical xenografts is in striking contrast to the much lower incidence seen with retinal xenografts. This suggests that there are immunological features unique to neocortex which incite host recognition and rejection.
我们利用移植到新生大鼠中枢神经系统(CNS)中的胚胎小鼠新皮质,研究了啮齿动物中枢神经系统中移植排斥的组织学和免疫学特征。使用标准组织学技术检查来自8 - 145日龄动物(n = 210)的移植物,以显示细胞形态和纤维投射。免疫组织化学技术用于识别移植物向宿主中枢神经系统的投射。18至30日龄动物的移植物排斥发生率为18%,但30日龄以上动物的排斥发生率突然升至73%。18日龄以下动物未见移植物排斥。在一小群在1月龄前后特定时间点处死的异种移植受体大鼠中,进行了详细的免疫组织化学研究,以将移植物的组织学外观与主要组织相容性复合体(MHC)I类和II类免疫反应性水平,以及移植物和宿主脑内的小胶质细胞、星形胶质细胞和淋巴细胞染色相关联。移植物内出现散在淋巴细胞所表现出的轻度排斥证据,与移植物内以及移植物 - 宿主界面处I类和II类免疫反应性的发展相一致,在一些动物中最早在24天时就已证实。在29日龄时,发生排斥的移植物在移植物内以及移植物 - 宿主界面处显示弥漫性MHC表达;相比之下,未发生排斥的移植物未显示MHC免疫反应性。34日龄的移植物常常表现出严重排斥,移植物内以及远离移植物的宿主实质内出现血管周围淋巴细胞套,同时宿主脑内MHC免疫反应性增加。在34日龄以上的移植物中,经常出现剧烈的排斥反应,移植物和周围宿主组织的细胞结构遭到破坏,且MHC抗原广泛表达。用环孢素A进行免疫抑制可有效避免排斥。新皮质异种移植物的高排斥发生率与视网膜异种移植物的低得多的发生率形成鲜明对比。这表明新皮质具有独特的免疫特征,可引发宿主识别和排斥。